Back
Rhythm Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
71
RYTM
Rhythm Pharmaceuticals
Last Price:
$89.38
Seasonality Move:
53.6%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight buying pressure.
Rhythm Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 80.07 | Buy |
| 20-day SMA: | 69.81 | Buy |
| 50-day SMA: | 65.4 | Buy |
| 200-day SMA: | 58.21 | Buy |
| 8-day EMA: | 67.59 | Buy |
| 20-day EMA: | 38.67 | Buy |
| 50-day EMA: | 18.16 | Buy |
| 200-day EMA: | 4.94 | Buy |
Rhythm Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 22.96 | Buy |
| Relative Strength Index (14 RSI): | 78.63 | Buy |
| Chaikin Money Flow: | 311828 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.78 - 78.9) | Buy |
| Bollinger Bands (100): | (52.44 - 68.82) | Buy |
Rhythm Pharmaceuticals Technical Analysis
| Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rhythm Pharmaceuticals Stock
Is Rhythm Pharmaceuticals Stock a Buy?
-
Rhythm Pharmaceuticals share price is 89.36 while RYTM 8-day simple moving average is 80.07, which is a Buy signal.
-
The stock price of RYTM is 89.36 while Rhythm Pharmaceuticals 20-day SMA is 69.81, which makes it a Buy.
-
Rhythm Pharmaceuticals 50-day simple moving average is 65.40 while RYTM share price is 89.36, making it a Buy technically.
-
RYTM stock price is 89.36 and Rhythm Pharmaceuticals 200-day simple moving average is 58.21, creating a Buy signal.
RYTM Technical Analysis vs Fundamental Analysis
Buy
71
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy or a Sell?
-
Rhythm Pharmaceuticals stock is rated a BuyThe current Rhythm Pharmaceuticals [RYTM] share price is $89.36. The Score for RYTM is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
Rhythm Pharmaceuticals Stock Info
Market Cap:
5.9B
Price in USD:
89.36
Share Volume:
852.3K
Rhythm Pharmaceuticals 52-Week Range
52-Week High:
94.80
52-Week Low:
40.61
Buy
71
Rhythm Pharmaceuticals (RYTM)
is a Buy
Rhythm Pharmaceuticals Share Price Forecast
-
What is the Rhythm Pharmaceuticals stock price today?The Rhythm Pharmaceuticals stock price is 89.36 USD today.
-
Will RYTM stock go up or go down?Rhythm Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Rhythm Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rhythm Pharmaceuticals is not overvalued.
Is Rhythm Pharmaceuticals Stock a Buy?
-
Rhythm Pharmaceuticals share price is 89.36 while RYTM 8-day exponential moving average is 67.59, which is a Buy signal.
-
The stock price of RYTM is 89.36 while Rhythm Pharmaceuticals 20-day EMA is 38.67, which makes it a Buy.
-
Rhythm Pharmaceuticals 50-day exponential moving average is 18.16 while RYTM share price is 89.36, making it a Buy technically.
-
RYTM stock price is 89.36 and Rhythm Pharmaceuticals 200-day simple moving average is 4.94, creating a Buy signal.
Fundamental Analysis of Rhythm Pharmaceuticals
Is Rhythm Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.12 per share, an increase this year of $1.23 per share, and an increase next year of $1.08 per share.
Technical Analysis of Rhythm Pharmaceuticals
Should I short Rhythm Pharmaceuticals stock?
-
RYTM Moving Average Covergence Divergence (MACD) indicator is 22.96, suggesting Rhythm Pharmaceuticals is a Buy
-
Rhythm Pharmaceuticals Relative Strength Index (RSI) is 78.63, which suggest Rhythm Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Rhythm Pharmaceuticals is (58.78 - 78.9), which suggest Rhythm Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Rhythm Pharmaceuticals is (52.44 - 68.82), which suggest Rhythm Pharmaceuticals is a Buy
* Rhythm Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.